
1. J Med Chem. 2015 Jul 23;58(14):5579-98. doi: 10.1021/acs.jmedchem.5b00606. Epub
2015 Jun 30.

Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate
Dehydrogenase (DHODH).

Lucas-Hourani M(1)(2), Munier-Lehmann H(3)(4), El Mazouni F(5), Malmquist
NA(6)(7)(8), Harpon J(6)(7)(8), Coutant EP(3)(4), Guillou S(3)(4), Helynck
O(3)(4), Noel A(3)(4), Scherf A(6)(7)(8), Phillips MA(5), Tangy F(1)(2), Vidalain
PO(1)(2), Janin YL(3)(4).

Author information: 
(1)†Unité de Génomique Virale et Vaccination, Département de Virologie, Institut 
Pasteur, 28 Rue du Dr. Roux, 75724 Paris Cedex 15, France.
(2)‡Unité Mixte de Recherche 3569, Centre National de la Recherche Scientifique, 
25 Rue du Dr. Roux, 75724 Paris Cedex 15, France.
(3)§Unité Mixte de Recherche 3523, Centre National de la Recherche Scientifique, 
28 Rue du Dr. Roux, 75724 Paris Cedex 15, France.
(4)∥Unité de Chimie et Biocatalyse, Département de Biologie Structurale et
Chimie, Institut Pasteur, 28 Rue du Dr. Roux, 75724 Paris Cedex 15, France.
(5)⊥Department of Pharmacology, University of Texas Southwestern Medical Center
at Dallas, 6001 Forest Park Boulevard, Dallas, Texas 75390-9041, United States.
(6)#Unité de Biologie des Interactions Hôte-Parasite, Département de
Parasitologie et Mycologie, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris
Cedex 15, France.
(7)^Unité 1201, Institut National de la Santé et de la Recherche Médicale, 25 Rue
du Dr. Roux, 75724 Paris Cedex 15, France.
(8)+Equipe de Recherche Labellisée 9195, Centre National de la Recherche
Scientifique, 25 Rue du Dr. Roux, 75724 Paris Cedex 15, France.

Following our discovery of human dihydroorotate dehydrogenase (DHODH) inhibition 
by 2-(3-alkoxy-1H-pyrazol-1-yl)pyrimidine derivatives as well as
2-(4-benzyl-3-ethoxy-5-methyl-1H-pyrazol-1-yl)-5-methylpyridine, we describe here
the syntheses and evaluation of an array of azine-bearing analogues. As in our
previous report, the structure-activity study of this series of human DHODH
inhibitors was based on a phenotypic assay measuring measles virus replication.
Among other inhibitors, this round of syntheses and biological evaluation
iteration led to the highly active
5-cyclopropyl-2-(4-(2,6-difluorophenoxy)-3-isopropoxy-5-methyl-1H-pyrazol-1-yl)-3
-fluoropyridine. Inhibition of DHODH by this compound was confirmed in an array
of in vitro assays, including enzymatic tests and cell-based assays for viral
replication and cellular growth. This molecule was found to be more active than
the known inhibitors of DHODH, brequinar and teriflunomide, thus opening
perspectives for its use as a tool or for the design of an original series of
immunosuppressive agent. Moreover, because other series of inhibitors of human
DHODH have been found to also affect Plasmodium falciparum DHODH, all the
compounds were assayed for their effect on P. falciparum growth. However, the
modest in vitro inhibition solely observed for two compounds did not correlate
with their inhibition of P. falciparum DHODH.

DOI: 10.1021/acs.jmedchem.5b00606 
PMCID: PMC4516315
PMID: 26079043  [Indexed for MEDLINE]

